High rates of resistance to piperacillin/tazobactam among Escherichia coli and Klebsiella pneumoniae strains isolated in a Greek hospital
- 1 September 1997
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 29 (1) , 39-41
- https://doi.org/10.1016/s0732-8893(97)00081-3
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coliAntimicrobial Agents and Chemotherapy, 1995
- β-Lactam/β-lactamase inhibitor combinations: Development, antibacterial activity and clinical applicationsInfection, 1995
- In vitro activities of various beta-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporinsAntimicrobial Agents and Chemotherapy, 1995
- Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers a reevaluation after five yearsDiagnostic Microbiology and Infectious Disease, 1995
- Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM beta-lactamases from clinical isolates of Escherichia coliAntimicrobial Agents and Chemotherapy, 1995
- beta-Lactamases in laboratory and clinical resistance.Clinical Microbiology Reviews, 1995
- On the incidence of antibiotic resistance among aerobic Gram-negative rods isolated in Greek hospitalsJournal of Hospital Infection, 1993
- Extended Broad-Spectrum -Lactamases Conferring Transferable Resistance to Newer -Lactam Agents in Enterobacteriaceae: Hospital Prevalence and Susceptibility PatternsClinical Infectious Diseases, 1988